Viewing Study NCT03966651


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-01-18 @ 2:05 AM
Study NCT ID: NCT03966651
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2019-05-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.
Sponsor: Institut Claudius Regaud
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PRRT (Peptide Receptor Radionuclide Therapy) View
None 177Lu-DOTATATE View